The ISPOR Research Presentation Podium and Poster Awards were established in 1998 to recognize the scientific merit of podium and poster presentations of the ISPOR Annual International Meetings, Annual European Congresses, Asia-Pacific and Latin America Conferences.
This year, the ISPOR judges evaluated over 80 podium presentations and over 100 nominated poster presentations. All podium presentations are considered for an award. Poster presentations in the top 20%, based on abstract review score, are considered and eligible for a poster presentation award.
Evaluations of scientific merit were based upon the following criteria:

Background provides appropriate perspective / context for the subject
Objectives / research questions are clearly stated
Research design / methods / modeling is appropriate and transparent (scores on this will determine winners in case of ties)
Data sources and/or sampling procedures are clear and appropriate
Data analyses are appropriate
Research objectives are met/addressed
Implications of findings are discussed
Factual information is kept separate from interpretations or implications
Abstract is presented in an unbiased manner
Clarity of presentation

A special thanks goes to Elizabeth Manias PhD, RPh, Professor, The University of Melbourne, Victoria Australia, and Chair, ISPOR Podium and Poster Research Presentation Awards Committee -- Podium Research Presentations, AS WELL AS TO David Thompson PhD, Vice President, Global Health Economics, i3 Innovus, Medford, MA, USA, Chair, ISPOR Podium and Poster Research Presentation Awards Committee -- Poster Research Presentations, for all their efforts in selecting the recipients!

THE RECIPIENTS ARE: . . .

ISPOR Best Podium Research Presentation Awards

Best General Podium Presentations

MO4 - RE-EXAMINING THE SPECIFICATION OF REGRESSION MODELS OF MULTINOMIAL RESPONSES: AN APPLICATION TO PREDICTING POST-STROKE DISCHARGE DISPOSITION
Bergtold J¹, Onukwugha E²
¹Kansas State University, Manhattan, KS, USA, ²University of Maryland School of Pharmacy, Baltimore, MD, USA

QL4 - VALIDATION OF THE TREATMENT RELATED IMPACT MEASURE FOR DIABETES TREATMENT AND DEVICE; TRIM-DIABETES AND TRIM-DIABETES DEVICE
Brod M¹, Hammer M², Christensen T², Bushnell D³
¹The BROD GROUP, Mill Valley, CA, USA, ²Novo Nordisk A/S, Bagsværd, Denmark, ³Health Research Associates, Inc, Mountlake Terrace, WA, USA

HM1 - EFFICIENCY AND ECONOMIC BENEFITS ASSOCIATED WITH THE USE OF A PAYER-BASED ELECTRONIC HEALTH RECORD IN AN EMERGENCY DEPARTMENT AMONG A HEALTH INSURED POPULATION
Daniel GW¹, Ewen E², Willey VJ³, Shirazi M⁴, Malone DC⁵
¹HealthCore, Wilmington, DE, USA, ²Christiana Care Health System, Newark, DE, USA, ³University of the Sciences in Philadelphia, Philadelphia, PA, USA, ⁴University of Arizona College of Medicine, Tucson, AZ, USA, ⁵University of Arizona College of Pharmacy, Tucson, AZ, USA

Best New Investigator Podium Research Presentations

PM3 - USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS: A VALUE OF INFORMATION ANALYSIS
Woods BS, Hawkins NS

Oxford Outcomes (UK), Oxford, UK

CM3 - THE IMPACT OF MEDICARE PART D ON ELDERLY PATIENTS' COMPLIANCE WITH STATINS

Zhang D, Henderson SC, Denarie MF

IMS Health, Blue Bell, PA, USA

ND3 - PRESCRIBING PATTERNS AMONG DEMENTIA PATIENTS AT THE VETERANS AFFAIRS MARYLAND HEALTH CARE SYSTEM (VAMHCS)
Rattinger GB¹, DeLisle S², Onukwugha E¹, Mullins CD¹

¹University of Maryland School of Pharmacy, Baltimore, MD, USA, ²University of Maryland School of Medicine and VA Maryland Health Care System, Baltimore, MD, USA

Best Student Podium Research Presentations

VA1 - A MARKOV MODEL EXAMINING THE PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF MASS VACCINATION USING LIVE ATTENUATED HUMAN ROTAVIRUS VACCINE IN A DEVELOPING ASIAN COUNTRY

Rose J¹, Molnar RL¹, Watts B², Singer ME¹

¹Case Western Reserve University School of Medicine, Cleveland, OH, USA, ²Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA

DU2 - RACIAL DISPARITIES AND BARRIER TO DRUG UTILIZATION IN PATIENTS WITH DIABETES IN THE UNITED STATES

Seetasith A, Zhang JX

Virginia Commonwealth University, Richmond, VA, USA

CV2 - COMPARISON OF CARDIOVASCULAR EVENT RATES IN SUBJECTS WITH TYPE-2 DIABETES MELLITUS WHO AUGMENTED FROM STATIN MONOTHERAPY TO STATIN PLUS FIBRATE COMBINATION THERAPY WITH THOSE WHO REMAINED ON STATIN MONOTHERAPY
Suh HS, Doctor JN

University of Southern California, Los Angeles, CA, USA

ISPOR Best Poster Research Presentation Awards

Best General Poster Research Presentations

PMH38 - THE ECONOMIC IMPACT OF GENERIC SWITCHING FOR PATIENTS WITH MAJOR DESPRESSIVE DISORDER (MDD) TREATED WITH ESCITALOPRAM OR A PATENTED SSRI
Lauzon V¹, Kaltenboek A², Yu AP², Ramakrishnan K², Marynchenko M¹, Wu EQ², Ben-Hamadi R², Erder MH³, Bose A³
¹Analysis Group, Inc., Montreal, QC, Canada, ²Analysis Group, Inc., Boston, MA, USA, ³Forest Research Institute, Jersey City, NJ, USA

PCN24 - THE ECONOMIC IMPLICATIONS OF RASBURICASE TREATMENT IN ADULT TUMOR LYSIS SYNDROME PATIENTS
Eaddy M¹, Seal B², Tangirala M³, O'Day K¹

¹Xcenda, Palm Harbor, FL, USA, ²Sanofi-Aventis, Bridgewater, NJ, USA, ³Smith Hanley Consulting Group LLC, Lake Mary, FL, USA

PDB10 - A COMPARISON OF ECONOMIC OUTCOMES BETWEEN ADHERENT AND NONADHERENT PATIENTS TREATED WITH ORAL ANTIDIABETIC MEDICATIONS
Hansen RA¹, Farley JF¹, Droege M², Maciejewski ML³

¹University of North Carolina, Chapel Hill, NC, USA, ²Takeda Pharmaceuticals North America, Inc, Deerfield, IL, USA, ³Center for Health Services Research in Primary Care, Durham, NC, USA

Best New Investigator Poster Research Presentations

	PCN105 - GUIDELINES AND CANCER SCREENING IN THE UNITED STATES AND CANADIAN HEALTH SYSTEMS Kadiyala S¹, Strumpf EC² ¹University of Washington, Seattle, WA, USA, ²McGill University, Monreal, QC, Canada
	PMS18 - ESTIMATION OF COSTS RELATED TO ADVERSE EVENTS IN NSAID TREATMENT OF OSTEOARTHRITIS – A COMPARISON BETWEEN CELECOXIB AND IBUPROFEN USING A VALIDATED MODEL Svedbom A¹, Borgstrom F¹, Holmstrom S², Miltenburger C³ ¹i3 Innovus, Stockholm, Sweden, ²NicOx, Sophia Antipolis, France, ³i3 Innovus, Berlin, Germany
	PCV35 - PHARMACOECONOMIC MODEL OF ENOXAPARIN VERSUS HEPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM IN MEDICAL PATIENTS Milani-Jr R¹, Follador W², Gonçalves J², Di Sena V² ¹São Paulo University, São Paulo, São Paulo, Brazil, ²Sanofi-Aventis, São Paulo, São Paulo, Brazi

Best Student Poster Research Presentations

PMC51 - TESTING THE ROLE OF TIME IN AFFECTING THE UNIDIMENSIONALITY IN EQ-5D USING THE 2002-2003 MEDICAL EXPENDITURE PANEL SURVEY (MEPS): A FACETS MODEL APPROACH
Gu NY, Doctor JN
University of Southern California, Los Angeles, CA, USA

PCV24 - DAILY ALCOHOL CONSUMPTION AND RACE/ETHNICITY: THEIR RELATIONSHIP TO STROKE OR CORONARY ARTERY DISEASE IN THE US ADULT POPULATION
Becker TL, Campbell HM

Department of Veterans Affairs Cooperative Studies Program, Albuquerque, NM, USA

PSY11 - ESTIMATION OF CAUSAL EFFECTS OF PHYSICAL ACTIVITY ON OBESITY BY A RECURSIVE BIVARIATE PROBIT MODEL
Kawatkar AA, Nichol MB

University of Southern California, Los Angeles, CA, USA

ISPOR would like to thank all the judges who have volunteered their time and efforts during the meeting to score podium and poster research presentations.